Go Pro
→ Louis Navellier: My #1 AI stock for 2026 (name & ticker inside) (From InvestorPlace) (Ad)tc pixel Free PHVS Stock Alerts

Pharvaris (PHVS) News Today

Pharvaris logo
$36.37 -1.63 (-4.29%)
Closing price 09/18/2026 04:00 PM Eastern
Extended Trading
$36.05 -0.32 (-0.88%)
As of 09/18/2026 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

Pharvaris Latest News

What Does Pharvaris (PHVS) Phase 3 HAE Success Mean Now?
 |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/does-pharvaris-phvs-phase-3-151211264.html
Engineers Gate Manager LP Makes New Investment in Pharvaris N.V. $PHVS
September 19 at 3:13 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-engineers-gate-manager-lp-makes-new-investment-in-pharvaris-nv-phvs-2026-09-19/
Robert Glassman Sells 8,667 Shares of Pharvaris (NASDAQ:PHVS) Stock
September 18 at 7:07 AM  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-phvs-insider-buying-and-selling-2026-09-18/
Wim Souverijns Sells 6,090 Shares of Pharvaris (NASDAQ:PHVS) Stock
September 18 at 5:57 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31031314
Insider Selling: Pharvaris (NASDAQ:PHVS) Director Sells $331,686.09 in Stock
September 17 at 11:07 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/insider-insider-selling-pharvaris-nasdaq-phvs-director-sells-33168609-in-stock-2026-09-17/
Insider Selling: Pharvaris (NASDAQ:PHVS) Insider Sells 6,090 Shares
September 17 at 7:07 AM  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-phvs-insider-buying-and-selling-2026-09-17/
Pharvaris (NASDAQ:PHVS) Insider Wim Souverijns Sells 6,090 Shares of Stock
September 16 at 3:07 PM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/insider-pharvaris-nasdaq-phvs-insider-wim-souverijns-sells-6090-shares-of-stock-2026-09-16/
Wim Souverijns Sells 20,000 Shares of Pharvaris (NASDAQ:PHVS) Stock
September 16 at 3:07 PM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/insider-wim-souverijns-sells-20000-shares-of-pharvaris-nasdaq-phvs-stock-2026-09-16/
Insider Selling: Pharvaris (NASDAQ:PHVS) CEO Sells $90,265.40 in Stock
September 16 at 5:52 AM  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-phvs-insider-buying-and-selling-2026-09-16/
Pharvaris N.V. $PHVS Position Trimmed by Squarepoint Ops LLC
September 16 at 4:00 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-pharvaris-nv-phvs-position-trimmed-by-squarepoint-ops-llc-2026-09-16/
Pharvaris N.V. (PHVS) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
September 15, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4946552-pharvaris-n-v-phvs-presents-at-morgan-stanley-24th-annual-global-healthcare-conference
Insider Selling: Pharvaris (NASDAQ:PHVS) CEO Sells $90,265.40 in Stock
September 15, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/insider-insider-selling-pharvaris-nasdaq-phvs-ceo-sells-9026540-in-stock-2026-09-15/
Peng Lu Sells 15,000 Shares of Pharvaris (NASDAQ:PHVS) Stock
September 15, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/insider-peng-lu-sells-15000-shares-of-pharvaris-nasdaq-phvs-stock-2026-09-15/
Pharvaris (NASDAQ:PHVS) Sees Unusually-High Trading Volume - Here's Why
September 15, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/price-pharvaris-nasdaq-phvs-sees-unusually-high-trading-volume-heres-why-2026-09-15/
Pharvaris NV consensus price target raised 20.08% to $59.77
September 15, 2026  |  msn.comhttps://www.msn.com/en-us/money/general/pharvaris-nv-consensus-price-target-raised-20-08-to-59-77/ar-AA2cfwI2
Pharvaris (NASDAQ:PHVS) Insider Anne Lesage Sells 30,000 Shares of Stock
September 15, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31024955
Insider Selling: Pharvaris (NASDAQ:PHVS) Insider Sells 30,000 Shares of Stock
September 15, 2026  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-phvs-insider-buying-and-selling-2026-09-15/
Anne Lesage Sells 30,000 Shares of Pharvaris (NASDAQ:PHVS) Stock
September 14, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/insider-anne-lesage-sells-30000-shares-of-pharvaris-nasdaq-phvs-stock-2026-09-14/
Insider Selling: Pharvaris (NASDAQ:PHVS) Director Sells $300,400.00 in Stock
September 14, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31022881
Analysts Conflicted on These Healthcare Names: Xeris Pharmaceuticals (XERS) and Pharvaris (PHVS)
September 12, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/PHVS/pressreleases/4554842/analysts-conflicted-on-these-healthcare-names-xeris-pharmaceuticals-xers-and-pharvaris-phvs/
Pharvaris (NASDAQ:PHVS) Director Sells $300,400.00 in Stock
September 12, 2026  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-phvs-insider-buying-and-selling-2026-09-12/
Pharvaris (NASDAQ:PHVS) Director Robert Glassman Sells 8,000 Shares of Stock
September 11, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/insider-pharvaris-nasdaq-phvs-director-robert-glassman-sells-8000-shares-of-stock-2026-09-11/
Pharvaris (NASDAQ:PHVS) Shares Up 5.8% - Here's Why
September 11, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/price-pharvaris-nasdaq-phvs-shares-up-58-heres-why-2026-09-11/
Pharvaris (PHVS) Gets a Buy from Leerink Partners
September 11, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/PHVS/pressreleases/4535167/pharvaris-phvs-gets-a-buy-from-leerink-partners/
Pharvaris (NASDAQ:PHVS) Stock Price Expected to Rise, Citizens Jmp Analyst Says
September 11, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31016217
Royal Bank Of Canada Boosts Pharvaris (NASDAQ:PHVS) Price Target to $62.00
September 11, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31016219
Pharvaris (PHVS) Reports an 83% HAE Attack-Rate Reduction. Can Oral Convenience Win?
September 10, 2026  |  insidermonkey.comhttps://www.insidermonkey.com/blog/pharvaris-phvs-reports-an-83-hae-attack-rate-reduction-can-oral-convenience-win-1835810/
Pharvaris N.V. (PHVS) Discusses Topline Results of Chapter-3 Phase III Study on Deucrictibant for Prophylactic Treatment of Hereditary Angioedema - Slideshow
September 10, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4945318-pharvaris-n-v-phvs-discusses-topline-results-of-chapterminus-3-phase-iii-study-on
RBC Capital Sticks to Its Buy Rating for Pharvaris (PHVS)
September 10, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/markets-news/Tipranks/4533205/rbc-capital-sticks-to-its-buy-rating-for-pharvaris-phvs/
Pharvaris (NASDAQ:PHVS) President Sells 15,000 Shares
September 10, 2026  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-phvs-insider-buying-and-selling-2026-09-10/
Pharvaris (NASDAQ:PHVS) Earns Buy Rating from HC Wainwright
September 10, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31013709
Wedbush Reaffirms "Outperform" Rating for Pharvaris (NASDAQ:PHVS)
September 10, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31013721
Pharvaris Could Gain Hereditary Angioedema Market Share on Deucrictibant XR Data, RBC Says
September 9, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/pharvaris-could-gain-hereditary-angioedema-151808709.html
Pharvaris: 'Strong Buy' Based On Deucrictibant PDUFA And Prophylaxis Trial Win
September 9, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4944532-pharvaris-strong-buy-based-on-deucrictibant-pdufa-and-prophylaxis-trial-win
Pharvaris (NASDAQ:PHVS) President Peng Lu Sells 15,000 Shares of Stock
September 9, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/insider-pharvaris-nasdaq-phvs-president-peng-lu-sells-15000-shares-of-stock-2026-09-09/
Royal Bank Of Canada Issues Positive Forecast for Pharvaris (NASDAQ:PHVS) Stock Price
September 9, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/analyst-royal-bank-of-canada-issues-positive-forecast-for-pharvaris-nasdaq-phvs-stock-price-2026-09-09/
Citizens Jmp Issues Positive Forecast for Pharvaris (NASDAQ:PHVS) Stock Price
September 9, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/analyst-citizens-jmp-issues-positive-forecast-for-pharvaris-nasdaq-phvs-stock-price-2026-09-09/
Wedbush Reaffirms Outperform Rating On Pharvaris; PT $42 After Positive Phase 3 CHAPTER-3 Data
September 9, 2026  |  rttnews.comhttps://www.rttnews.com/3689439/wedbush-reaffirms-outperform-rating-on-pharvaris-pt-42-after-positive-phase-3-chapter-3-data.aspx
RBC Raises Price Target on Pharvaris to $62 From $52, Keeps Outperform, Speculative Risk
September 9, 2026  |  marketscreener.comM
Analysts Set Pharvaris N.V. (NASDAQ:PHVS) Price Target at $51.08
September 9, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31012994
Pharvaris Shares Jump 16% On Positive Phase 3 HAE Study Results
September 8, 2026  |  rttnews.comhttps://www.rttnews.com/3689231/pharvaris-shares-jump-16-on-positive-phase-3-hae-study-results.aspx
Pharvaris Shares Surge 27% After Deucrictibant Phase 3 Trial Meets Primary Endpoint
September 8, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/pharvaris-shares-surge-27-deucrictibant-125600200.html
Biotech stocks, with 'blowout' and 'bull case' results, rocket to record highs
September 8, 2026  |  msn.comhttps://www.msn.com/en-us/news/other/biotech-stocks-with-blowout-and-bull-case-results-rocket-to-record-highs/ar-AA2bOpm2
Pharvaris N.V. (PHVS) Discusses Topline Results of Chapter-3 Phase III Study on Deucrictibant for Prophylactic Treatment of Hereditary Angioedema Transcript
September 8, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4943847-pharvaris-n-v-phvs-discusses-topline-results-of-chapterminus-3-phase-iii-study-on
HC Wainwright Reaffirms "Buy" Rating for Pharvaris (NASDAQ:PHVS)
September 8, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/analyst-hc-wainwright-reaffirms-buy-rating-for-pharvaris-nasdaq-phvs-2026-09-08/
Pharvaris (NASDAQ:PHVS) Sets New 1-Year High - Time to Buy?
September 8, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/price-pharvaris-nasdaq-phvs-sets-new-1-year-high-time-to-buy-2026-09-08/
Pharvaris Unveils CHAPTER-3 Phase 3 Topline Data and HAE Pipeline Milestones
September 8, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/pharvaris-unveils-chapter-3-phase-3-topline-data-and-hae-pipeline-milestones?utm_source=marketbeat.com&utm_medium=referral
Wedbush Reaffirms Outperform Rating for Pharvaris (NASDAQ:PHVS)
September 8, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/analyst-wedbush-reaffirms-outperform-rating-for-pharvaris-nasdaq-phvs-2026-09-08/
Pharvaris Reports Positive Phase 3 CHAPTER-3 Results For Deucrictibant XR In HAE Prophylaxis
September 8, 2026  |  rttnews.comhttps://www.rttnews.com/3689116/pharvaris-reports-positive-phase-3-chapter-3-results-for-deucrictibant-xr-in-hae-prophylaxis.aspx
Pharvaris Says Phase 3 Deucrictibant XR Trial Meets Endpoints in Hereditary Angioedema
September 8, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/pharvaris-says-phase-3-deucrictibant-113926862.html

Pharvaris Media Mentions By Week

Pharvaris Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

PHVS
News Sentiment
▼
0.41

0.56
▲
Average
Healthcare
News Sentiment

Pharvaris News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

PHVS Articles
This Week
▼
24

6
▲
PHVS Articles
Average Week

Pharvaris Trends on MarketBeat

This week vs. last week
New Followers
1
-75%
Searches
1
-86%
Page Views
4,518
-17%
Get Pharvaris News Delivered to You Automatically

Sign up to receive the latest news and ratings for PHVS and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools

Related Companies
News and Trends Tools

MarketBeat tracks news from more than one hundred trusted media outlets in real time, with the most recent headline for Pharvaris dated 9/19/2026.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Small Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid
A small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...
Altimetry | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
These gold assets are priced for $1,800 gold [it's over $4,000]
Gold's major miners are generating record free cash flow, with margins as high as 75 percent even after gold's...
Golden Portfolio | Sponsoredtc pixel
Here’s Why Trump Won’t End The Iran War
Trump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...
Banyan Hill Publishing | Sponsoredtc pixel
Your book is inside
The "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...
Profits Run | Sponsoredtc pixel